Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view.

World J Cardiol · 2023 · PMC10523195 · PMID 37771340

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely significantlyno p-value reported

In the ENGAGE AF-TIMI 48 study, the higher dose of edoxaban (60 mg daily) increased (+ 23%), although barely significantly, the risk of major GIB in comparison to warfarin[ 63 ].

also in 36 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.